Optic Neuropathy Drug Market, Global Outlook and Forecast 2022-2028

March 2022 | 73 pages | ID: O37A2FBE968CEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Optic Neuropathy Drug in global, including the following market information:

Global Optic Neuropathy Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Optic Neuropathy Drug Market Sales, 2017-2022, 2023-2028, (K Pcs)

Global top five Optic Neuropathy Drug companies in 2021 (%)

The global Optic Neuropathy Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

BA-240 Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Optic Neuropathy Drug include Amgen Inc, BioAxone BioSciences Inc, Ironwood Pharmaceuticals Inc, Quark Pharmaceuticals Inc, Regenera Pharma Ltd and Regeneron Pharmaceuticals Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Optic Neuropathy Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Optic Neuropathy Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Optic Neuropathy Drug Market Segment Percentages, by Type, 2021 (%)

• BA-240
• IWP-953
• LM-22A4
• Others

Global Optic Neuropathy Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Optic Neuropathy Drug Market Segment Percentages, by Application, 2021 (%)

• Clinic
• Hospital
• Homecare

Global Optic Neuropathy Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Optic Neuropathy Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Optic Neuropathy Drug revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Optic Neuropathy Drug revenues share in global market, 2021 (%)

Key companies Optic Neuropathy Drug sales in global market, 2017-2022 (Estimated), (K Pcs)

Key companies Optic Neuropathy Drug sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Amgen Inc
• BioAxone BioSciences Inc
• Ironwood Pharmaceuticals Inc
• Quark Pharmaceuticals Inc
• Regenera Pharma Ltd
• Regeneron Pharmaceuticals Inc

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Optic Neuropathy Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Optic Neuropathy Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL OPTIC NEUROPATHY DRUG OVERALL MARKET SIZE

2.1 Global Optic Neuropathy Drug Market Size: 2021 VS 2028
2.2 Global Optic Neuropathy Drug Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Optic Neuropathy Drug Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Optic Neuropathy Drug Players in Global Market
3.2 Top Global Optic Neuropathy Drug Companies Ranked by Revenue
3.3 Global Optic Neuropathy Drug Revenue by Companies
3.4 Global Optic Neuropathy Drug Sales by Companies
3.5 Global Optic Neuropathy Drug Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Optic Neuropathy Drug Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Optic Neuropathy Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Optic Neuropathy Drug Players in Global Market
  3.8.1 List of Global Tier 1 Optic Neuropathy Drug Companies
  3.8.2 List of Global Tier 2 and Tier 3 Optic Neuropathy Drug Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Optic Neuropathy Drug Market Size Markets, 2021 & 2028
  4.1.2 BA-240
  4.1.3 IWP-953
  4.1.4 LM-22A4
  4.1.5 Others
4.2 By Type - Global Optic Neuropathy Drug Revenue & Forecasts
  4.2.1 By Type - Global Optic Neuropathy Drug Revenue, 2017-2022
  4.2.2 By Type - Global Optic Neuropathy Drug Revenue, 2023-2028
  4.2.3 By Type - Global Optic Neuropathy Drug Revenue Market Share, 2017-2028
4.3 By Type - Global Optic Neuropathy Drug Sales & Forecasts
  4.3.1 By Type - Global Optic Neuropathy Drug Sales, 2017-2022
  4.3.2 By Type - Global Optic Neuropathy Drug Sales, 2023-2028
  4.3.3 By Type - Global Optic Neuropathy Drug Sales Market Share, 2017-2028
4.4 By Type - Global Optic Neuropathy Drug Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Optic Neuropathy Drug Market Size, 2021 & 2028
  5.1.2 Clinic
  5.1.3 Hospital
  5.1.4 Homecare
5.2 By Application - Global Optic Neuropathy Drug Revenue & Forecasts
  5.2.1 By Application - Global Optic Neuropathy Drug Revenue, 2017-2022
  5.2.2 By Application - Global Optic Neuropathy Drug Revenue, 2023-2028
  5.2.3 By Application - Global Optic Neuropathy Drug Revenue Market Share, 2017-2028
5.3 By Application - Global Optic Neuropathy Drug Sales & Forecasts
  5.3.1 By Application - Global Optic Neuropathy Drug Sales, 2017-2022
  5.3.2 By Application - Global Optic Neuropathy Drug Sales, 2023-2028
  5.3.3 By Application - Global Optic Neuropathy Drug Sales Market Share, 2017-2028
5.4 By Application - Global Optic Neuropathy Drug Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Optic Neuropathy Drug Market Size, 2021 & 2028
6.2 By Region - Global Optic Neuropathy Drug Revenue & Forecasts
  6.2.1 By Region - Global Optic Neuropathy Drug Revenue, 2017-2022
  6.2.2 By Region - Global Optic Neuropathy Drug Revenue, 2023-2028
  6.2.3 By Region - Global Optic Neuropathy Drug Revenue Market Share, 2017-2028
6.3 By Region - Global Optic Neuropathy Drug Sales & Forecasts
  6.3.1 By Region - Global Optic Neuropathy Drug Sales, 2017-2022
  6.3.2 By Region - Global Optic Neuropathy Drug Sales, 2023-2028
  6.3.3 By Region - Global Optic Neuropathy Drug Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Optic Neuropathy Drug Revenue, 2017-2028
  6.4.2 By Country - North America Optic Neuropathy Drug Sales, 2017-2028
  6.4.3 US Optic Neuropathy Drug Market Size, 2017-2028
  6.4.4 Canada Optic Neuropathy Drug Market Size, 2017-2028
  6.4.5 Mexico Optic Neuropathy Drug Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Optic Neuropathy Drug Revenue, 2017-2028
  6.5.2 By Country - Europe Optic Neuropathy Drug Sales, 2017-2028
  6.5.3 Germany Optic Neuropathy Drug Market Size, 2017-2028
  6.5.4 France Optic Neuropathy Drug Market Size, 2017-2028
  6.5.5 U.K. Optic Neuropathy Drug Market Size, 2017-2028
  6.5.6 Italy Optic Neuropathy Drug Market Size, 2017-2028
  6.5.7 Russia Optic Neuropathy Drug Market Size, 2017-2028
  6.5.8 Nordic Countries Optic Neuropathy Drug Market Size, 2017-2028
  6.5.9 Benelux Optic Neuropathy Drug Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Optic Neuropathy Drug Revenue, 2017-2028
  6.6.2 By Region - Asia Optic Neuropathy Drug Sales, 2017-2028
  6.6.3 China Optic Neuropathy Drug Market Size, 2017-2028
  6.6.4 Japan Optic Neuropathy Drug Market Size, 2017-2028
  6.6.5 South Korea Optic Neuropathy Drug Market Size, 2017-2028
  6.6.6 Southeast Asia Optic Neuropathy Drug Market Size, 2017-2028
  6.6.7 India Optic Neuropathy Drug Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Optic Neuropathy Drug Revenue, 2017-2028
  6.7.2 By Country - South America Optic Neuropathy Drug Sales, 2017-2028
  6.7.3 Brazil Optic Neuropathy Drug Market Size, 2017-2028
  6.7.4 Argentina Optic Neuropathy Drug Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Optic Neuropathy Drug Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Optic Neuropathy Drug Sales, 2017-2028
  6.8.3 Turkey Optic Neuropathy Drug Market Size, 2017-2028
  6.8.4 Israel Optic Neuropathy Drug Market Size, 2017-2028
  6.8.5 Saudi Arabia Optic Neuropathy Drug Market Size, 2017-2028
  6.8.6 UAE Optic Neuropathy Drug Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Amgen Inc
  7.1.1 Amgen Inc Corporate Summary
  7.1.2 Amgen Inc Business Overview
  7.1.3 Amgen Inc Optic Neuropathy Drug Major Product Offerings
  7.1.4 Amgen Inc Optic Neuropathy Drug Sales and Revenue in Global (2017-2022)
  7.1.5 Amgen Inc Key News
7.2 BioAxone BioSciences Inc
  7.2.1 BioAxone BioSciences Inc Corporate Summary
  7.2.2 BioAxone BioSciences Inc Business Overview
  7.2.3 BioAxone BioSciences Inc Optic Neuropathy Drug Major Product Offerings
  7.2.4 BioAxone BioSciences Inc Optic Neuropathy Drug Sales and Revenue in Global (2017-2022)
  7.2.5 BioAxone BioSciences Inc Key News
7.3 Ironwood Pharmaceuticals Inc
  7.3.1 Ironwood Pharmaceuticals Inc Corporate Summary
  7.3.2 Ironwood Pharmaceuticals Inc Business Overview
  7.3.3 Ironwood Pharmaceuticals Inc Optic Neuropathy Drug Major Product Offerings
  7.3.4 Ironwood Pharmaceuticals Inc Optic Neuropathy Drug Sales and Revenue in Global (2017-2022)
  7.3.5 Ironwood Pharmaceuticals Inc Key News
7.4 Quark Pharmaceuticals Inc
  7.4.1 Quark Pharmaceuticals Inc Corporate Summary
  7.4.2 Quark Pharmaceuticals Inc Business Overview
  7.4.3 Quark Pharmaceuticals Inc Optic Neuropathy Drug Major Product Offerings
  7.4.4 Quark Pharmaceuticals Inc Optic Neuropathy Drug Sales and Revenue in Global (2017-2022)
  7.4.5 Quark Pharmaceuticals Inc Key News
7.5 Regenera Pharma Ltd
  7.5.1 Regenera Pharma Ltd Corporate Summary
  7.5.2 Regenera Pharma Ltd Business Overview
  7.5.3 Regenera Pharma Ltd Optic Neuropathy Drug Major Product Offerings
  7.5.4 Regenera Pharma Ltd Optic Neuropathy Drug Sales and Revenue in Global (2017-2022)
  7.5.5 Regenera Pharma Ltd Key News
7.6 Regeneron Pharmaceuticals Inc
  7.6.1 Regeneron Pharmaceuticals Inc Corporate Summary
  7.6.2 Regeneron Pharmaceuticals Inc Business Overview
  7.6.3 Regeneron Pharmaceuticals Inc Optic Neuropathy Drug Major Product Offerings
  7.6.4 Regeneron Pharmaceuticals Inc Optic Neuropathy Drug Sales and Revenue in Global (2017-2022)
  7.6.5 Regeneron Pharmaceuticals Inc Key News

8 GLOBAL OPTIC NEUROPATHY DRUG PRODUCTION CAPACITY, ANALYSIS

8.1 Global Optic Neuropathy Drug Production Capacity, 2017-2028
8.2 Optic Neuropathy Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Optic Neuropathy Drug Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 OPTIC NEUROPATHY DRUG SUPPLY CHAIN ANALYSIS

10.1 Optic Neuropathy Drug Industry Value Chain
10.2 Optic Neuropathy Drug Upstream Market
10.3 Optic Neuropathy Drug Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Optic Neuropathy Drug Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Optic Neuropathy Drug in Global Market
Table 2. Top Optic Neuropathy Drug Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Optic Neuropathy Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Optic Neuropathy Drug Revenue Share by Companies, 2017-2022
Table 5. Global Optic Neuropathy Drug Sales by Companies, (K Pcs), 2017-2022
Table 6. Global Optic Neuropathy Drug Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Optic Neuropathy Drug Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers Optic Neuropathy Drug Product Type
Table 9. List of Global Tier 1 Optic Neuropathy Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Optic Neuropathy Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Optic Neuropathy Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Optic Neuropathy Drug Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Optic Neuropathy Drug Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Optic Neuropathy Drug Sales (K Pcs), 2017-2022
Table 15. By Type - Global Optic Neuropathy Drug Sales (K Pcs), 2023-2028
Table 16. By Application – Global Optic Neuropathy Drug Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Optic Neuropathy Drug Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Optic Neuropathy Drug Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Optic Neuropathy Drug Sales (K Pcs), 2017-2022
Table 20. By Application - Global Optic Neuropathy Drug Sales (K Pcs), 2023-2028
Table 21. By Region – Global Optic Neuropathy Drug Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Optic Neuropathy Drug Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Optic Neuropathy Drug Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Optic Neuropathy Drug Sales (K Pcs), 2017-2022
Table 25. By Region - Global Optic Neuropathy Drug Sales (K Pcs), 2023-2028
Table 26. By Country - North America Optic Neuropathy Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Optic Neuropathy Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Optic Neuropathy Drug Sales, (K Pcs), 2017-2022
Table 29. By Country - North America Optic Neuropathy Drug Sales, (K Pcs), 2023-2028
Table 30. By Country - Europe Optic Neuropathy Drug Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Optic Neuropathy Drug Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Optic Neuropathy Drug Sales, (K Pcs), 2017-2022
Table 33. By Country - Europe Optic Neuropathy Drug Sales, (K Pcs), 2023-2028
Table 34. By Region - Asia Optic Neuropathy Drug Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Optic Neuropathy Drug Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Optic Neuropathy Drug Sales, (K Pcs), 2017-2022
Table 37. By Region - Asia Optic Neuropathy Drug Sales, (K Pcs), 2023-2028
Table 38. By Country - South America Optic Neuropathy Drug Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Optic Neuropathy Drug Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Optic Neuropathy Drug Sales, (K Pcs), 2017-2022
Table 41. By Country - South America Optic Neuropathy Drug Sales, (K Pcs), 2023-2028
Table 42. By Country - Middle East & Africa Optic Neuropathy Drug Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Optic Neuropathy Drug Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Optic Neuropathy Drug Sales, (K Pcs), 2017-2022
Table 45. By Country - Middle East & Africa Optic Neuropathy Drug Sales, (K Pcs), 2023-2028
Table 46. Amgen Inc Corporate Summary
Table 47. Amgen Inc Optic Neuropathy Drug Product Offerings
Table 48. Amgen Inc Optic Neuropathy Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. BioAxone BioSciences Inc Corporate Summary
Table 50. BioAxone BioSciences Inc Optic Neuropathy Drug Product Offerings
Table 51. BioAxone BioSciences Inc Optic Neuropathy Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. Ironwood Pharmaceuticals Inc Corporate Summary
Table 53. Ironwood Pharmaceuticals Inc Optic Neuropathy Drug Product Offerings
Table 54. Ironwood Pharmaceuticals Inc Optic Neuropathy Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 55. Quark Pharmaceuticals Inc Corporate Summary
Table 56. Quark Pharmaceuticals Inc Optic Neuropathy Drug Product Offerings
Table 57. Quark Pharmaceuticals Inc Optic Neuropathy Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 58. Regenera Pharma Ltd Corporate Summary
Table 59. Regenera Pharma Ltd Optic Neuropathy Drug Product Offerings
Table 60. Regenera Pharma Ltd Optic Neuropathy Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 61. Regeneron Pharmaceuticals Inc Corporate Summary
Table 62. Regeneron Pharmaceuticals Inc Optic Neuropathy Drug Product Offerings
Table 63. Regeneron Pharmaceuticals Inc Optic Neuropathy Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 64. Optic Neuropathy Drug Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
Table 65. Global Optic Neuropathy Drug Capacity Market Share of Key Manufacturers, 2020-2022
Table 66. Global Optic Neuropathy Drug Production by Region, 2017-2022 (K Pcs)
Table 67. Global Optic Neuropathy Drug Production by Region, 2023-2028 (K Pcs)
Table 68. Optic Neuropathy Drug Market Opportunities & Trends in Global Market
Table 69. Optic Neuropathy Drug Market Drivers in Global Market
Table 70. Optic Neuropathy Drug Market Restraints in Global Market
Table 71. Optic Neuropathy Drug Raw Materials
Table 72. Optic Neuropathy Drug Raw Materials Suppliers in Global Market
Table 73. Typical Optic Neuropathy Drug Downstream
Table 74. Optic Neuropathy Drug Downstream Clients in Global Market
Table 75. Optic Neuropathy Drug Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Optic Neuropathy Drug Segment by Type
Figure 2. Optic Neuropathy Drug Segment by Application
Figure 3. Global Optic Neuropathy Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Optic Neuropathy Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Optic Neuropathy Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. Optic Neuropathy Drug Sales in Global Market: 2017-2028 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Optic Neuropathy Drug Revenue in 2021
Figure 9. By Type - Global Optic Neuropathy Drug Sales Market Share, 2017-2028
Figure 10. By Type - Global Optic Neuropathy Drug Revenue Market Share, 2017-2028
Figure 11. By Type - Global Optic Neuropathy Drug Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global Optic Neuropathy Drug Sales Market Share, 2017-2028
Figure 13. By Application - Global Optic Neuropathy Drug Revenue Market Share, 2017-2028
Figure 14. By Application - Global Optic Neuropathy Drug Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global Optic Neuropathy Drug Sales Market Share, 2017-2028
Figure 16. By Region - Global Optic Neuropathy Drug Revenue Market Share, 2017-2028
Figure 17. By Country - North America Optic Neuropathy Drug Revenue Market Share, 2017-2028
Figure 18. By Country - North America Optic Neuropathy Drug Sales Market Share, 2017-2028
Figure 19. US Optic Neuropathy Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Optic Neuropathy Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Optic Neuropathy Drug Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Optic Neuropathy Drug Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Optic Neuropathy Drug Sales Market Share, 2017-2028
Figure 24. Germany Optic Neuropathy Drug Revenue, (US$, Mn), 2017-2028
Figure 25. France Optic Neuropathy Drug Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Optic Neuropathy Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Optic Neuropathy Drug Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Optic Neuropathy Drug Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Optic Neuropathy Drug Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Optic Neuropathy Drug Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Optic Neuropathy Drug Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Optic Neuropathy Drug Sales Market Share, 2017-2028
Figure 33. China Optic Neuropathy Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Optic Neuropathy Drug Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Optic Neuropathy Drug Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Optic Neuropathy Drug Revenue, (US$, Mn), 2017-2028
Figure 37. India Optic Neuropathy Drug Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Optic Neuropathy Drug Revenue Market Share, 2017-2028
Figure 39. By Country - South America Optic Neuropathy Drug Sales Market Share, 2017-2028
Figure 40. Brazil Optic Neuropathy Drug Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Optic Neuropathy Drug Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Optic Neuropathy Drug Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Optic Neuropathy Drug Sales Market Share, 2017-2028
Figure 44. Turkey Optic Neuropathy Drug Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Optic Neuropathy Drug Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Optic Neuropathy Drug Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Optic Neuropathy Drug Revenue, (US$, Mn), 2017-2028
Figure 48. Global Optic Neuropathy Drug Production Capacity (K Pcs), 2017-2028
Figure 49. The Percentage of Production Optic Neuropathy Drug by Region, 2021 VS 2028
Figure 50. Optic Neuropathy Drug Industry Value Chain
Figure 51. Marketing Channels